Dân tộc, Chủng tộc và Các Yếu Tố Liên Quan Đến Độ Nặng Bệnh Võng Mạc Tại Thời Điểm Xuất Nhập Trong Thử Nghiệm Đái Tháo Đường Của Bộ Cựu Chiến Binh
Tóm tắt
Từ khóa
Tài liệu tham khảo
UK Perspective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853, 1998
Ohkubo Y, Kishikawa H, Araki E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res and Clin Pract 28: 103–117, 1995
Diabetes Control and Complications Trial Research Group (DCCT): The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977–994, 1993
Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W: Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2 (Veterans Affairs Diabetes Trial). J Diabetes Compl 17: 314–322, 2003
Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N: Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): a feasibility study. Diabetes Care 19: 1375–1381, 1996
Reaven PD, Sacks J, VADT Investigators: Reduced coronary and abdominal artery calcification in Hispanics with type 2 diabetes. Diabetes Care 27: 1115–1120, 2004
Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD: Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? Diabetes Care 21: 1230–1235, 1998
Haffner SM, Fong D, Stern M, Pugh J, Hazuda H, Patterson J, van Heuven W, Klein R: Diabetic retinopathy in Mexican Americans and Non-Hispanic whites. Diabetes 37: 878–884, 1988
The Eye Disease Prevalence Research Group: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552–563, 2004
Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM: Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes: San Luis Valley Diabetes Study, Colorado. Diabetes Care 21: 53–61, 1998
Hamman RF, Mayer EJ, Moo-Young GA, Hilderbrandt W, Marshall JA, Baxter J: Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley Diabetes Study. Diabetes 38: 1231–1237, 1989
West SK, Klein R, Rodriguez J, Beatriz M, Broman MS, Rosario S, Snyder R: Diabetes and diabetic retinopathy in a Mexican-American population. Diabetes Care 24: 1204–1209, 2001
Harris EL, Feldman S, Robinson CR, Sherman S, Georgopoulos A: Racial differences in the relationship between blood pressure and the risk of retinopathy among individuals with NIDDM. Diabetes Care 16: 748–754, 1993
Harris EL, Sherman SH, Georgopoulos A: Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care 22: 779–783, 1999
Mansfield MW, Grant PJ: Fibrinolysis and diabetic retinopathy in NIDDM. Diabetes Care 18: 1577–1581, 1995
Cho YW, Yang DH, OH DY, Baick SH, Kim SK, Kim SH, Hong SY: Plasma t-PA and PAI-1 antigen concentration in non-insulin dependent diabetic patients: implication for diabetic retinopathy. Diabetes Res Clin Pract 22: 123–128, 1994
Vekasi J, Marton ZS, Kesmarky G, Cser A, Russai R, Horvath B: Hemorheological alterations in patients with diabetic retinopathy. Clin Hemorheol Microcirc 24: 59–64, 2001
Asakawa H, Tokunaga K, Kawakami F: Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 14: 121–126, 2000
Brown JB, Pedula KL Summers KH: Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 26: 2637–2642, 2003
Klein R: Diabetes mellitus: oculopathy. In Endocrinology. 4th ed. DeGroot L, Jameson JL, Eds. Philadelphia, WB Saunders, 2001, p. 857–867
Schrier RW, Estacio RO, Esler A, Mehler P: Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria retinopathy, and strokes. Kidney Int 61: 1066–1097, 2002
UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 317: 703–713, 1998
Anderson R, Abraira C, Duckworth W, McCarren M, Zimering M, Veterans Affairs Diabetes Trial (VADT) Group: Blood pressure (BP) control in the VADT. Presented at the Endocrine Society 85th Annual Meeting, 19–22 June 2003,Philadelphia, Pennsylvania, p. 750
Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantree K: The association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 114: 1079–1084, 1996
Klein BE, Moss SE, Klein R, Surawicz TS: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy in hard exudate. Ophthalmology 98: 1261–1265, 1991
Kirkman MS, McCarren M, Duckworth W, Abraira C, VADT Group: Cardiovascular disease correlates with traditional risk factors but not with glycemic control in established type 2 diabetes (Abstract). Diabetes 53 (Suppl. 2): A77, 2004